| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/24/2004 | CA2508264A1 Methods of treatment of ulcerative colitis with anti-cd3 antibodies |
| 06/24/2004 | CA2507496A1 Molecular determinants of myeloma bone disease and uses thereof |
| 06/23/2004 | EP1431311A1 Immunotherapy of B-cell malignancies using anti-CD22 and anti-CD20 antibodies in combination |
| 06/23/2004 | EP1431310A1 RECOMBINANT ANTI−OSTEOPONTIN ANTIBODY AND USE THEREOF |
| 06/23/2004 | EP1430152A2 Gene and protein relating to hepatocellular carcinoma |
| 06/23/2004 | EP1430146A2 Novel nucleic acids and polypeptides |
| 06/23/2004 | EP1430133A2 A soluble toll-like receptor |
| 06/23/2004 | EP1430130A2 Nucleic acid-associated proteins |
| 06/23/2004 | EP1430129A2 Asip-related proteins |
| 06/23/2004 | EP1430126A1 Dna sequences for human angiogenesis genes |
| 06/23/2004 | EP1430083A2 T1r taste receptors and genes encoding same |
| 06/23/2004 | EP1430081A2 Brca1/acc alpha molecular complexes, diagnostic and therapeutic applications |
| 06/23/2004 | EP1429845A2 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 06/23/2004 | EP1429806A2 Extracellular massengers |
| 06/23/2004 | EP1429805A2 Use of antibodies having high affinity for soluble ass to treat conditions and diseases related to ass |
| 06/23/2004 | EP1429797A2 Diagnosis and treatment of malignant neoplasms |
| 06/23/2004 | EP1429650A2 Alternatively spliced circulating tissue factor |
| 06/23/2004 | EP1429623A1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses |
| 06/23/2004 | EP1268801B1 A method for in vitro molecular evolution of antibody function |
| 06/23/2004 | EP1131411B1 Suppression of xenotransplant rejection |
| 06/23/2004 | EP1032671B1 Mammalian cytokine-like polypeptide-10 |
| 06/23/2004 | EP0977861B1 Mammalian cytokine-like factor 7 |
| 06/23/2004 | CN1507452A Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 06/23/2004 | CN1507355A Combination therapy using anti-EGFR antibodies and anti-hormonal agents |
| 06/23/2004 | CN1507354A Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 06/23/2004 | CN1507353A Compositions for use in treating IGE-associated disorders |
| 06/23/2004 | CN1506376A Embedded CD25-resisting monoclonal antibody and its coding sequence and application |
| 06/23/2004 | CN1154732C Synthetic HPV6/11 hybrid Li DNA encoding human papliomavirus type 11 L1 protein |
| 06/23/2004 | CN1154731C Gene of hop latent virus and methods for detecting the same |
| 06/23/2004 | CN1154730C Compounds and methods for diagnosis of tuberculosis |
| 06/23/2004 | CN1154729C Staphylokinase derivs |
| 06/23/2004 | CN1154726C OB protein derivatives having prolonged half-life |
| 06/23/2004 | CN1154659C Novel anti-AIDS immunotoxins |
| 06/22/2004 | US6753420 Anticancer agents |
| 06/22/2004 | US6753417 Peptide for use in the diagnosis and prevention of immunological and infectious disorders |
| 06/22/2004 | US6753412 Human Eag2 |
| 06/22/2004 | US6753314 Protein-protein complexes and methods of using same |
| 06/22/2004 | US6753183 Immunologically active proteins from Borrelia burgdorferi |
| 06/22/2004 | US6753176 Genetic engineering; antiarthritic agents |
| 06/22/2004 | US6753166 Nucleotide sequences coding polypeptides for use in the treatment of inflammatory and autoimmune diseases |
| 06/22/2004 | US6753156 Homogeneous method for detecting and/or determining phosphorylating activity in a biological material |
| 06/22/2004 | US6753152 High affinity humanized anti-tag-72 monoclonalantibodies |
| 06/22/2004 | US6753136 Expressing preferential amino acid sequences on surface of viruses; obtain genetically engineered viruses, express amino acid sequences, moniltor viral coat for presence of preferential amino acid sequences |
| 06/22/2004 | US6752991 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/22/2004 | US6752990 High affinity humanized anti-TAG-72 monoclonal antibodies |
| 06/22/2004 | CA2210620C Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
| 06/22/2004 | CA2176926C .alpha.v.beta.3 integrin as a predictor of endometriosis |
| 06/22/2004 | CA2142197C Monoclonal antibody recognizing fk506-binding protein method for assaying fk506-binding protein level, and kit therefor |
| 06/22/2004 | CA2110702C Process for the production of a viable cell culture infected by a multiple sclerosis associated virus |
| 06/19/2004 | CA2452946A1 Detection and diagnosis of transmissible spongiform encephalopathies |
| 06/17/2004 | WO2004051280A2 Identification of agonistic autoantibodies |
| 06/17/2004 | WO2004051273A1 Method of assaying elastin digestion product and assay kit, method of detecting aortic dissection and detection kit |
| 06/17/2004 | WO2004051268A1 Assay for identifying antibody producing cells |
| 06/17/2004 | WO2004051266A1 Microwell array chip for detecting antigen-specific lymphocyte, method of detecting antigen-specific lymphocyte and method of cloning antigen-specific lymphocyte antigen receptor gene |
| 06/17/2004 | WO2004050901A2 Method for the selection of cells producing specifically binding molecules |
| 06/17/2004 | WO2004050895A2 Methods and compositions for inducing apoptosis in cancer cells |
| 06/17/2004 | WO2004050868A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof |
| 06/17/2004 | WO2004050867A1 MODIFIED L49-sFv EXHIBITING INCREASED STABILITY AND METHODS OF USE THEREOF |
| 06/17/2004 | WO2004050851A2 Prion protein ligands and methods of use |
| 06/17/2004 | WO2004050850A2 Antibodies directed to phospholipase a2 and uses thereof |
| 06/17/2004 | WO2004050849A2 Recombinant immunotoxin and use in treating tumors |
| 06/17/2004 | WO2004050847A2 Modified antibodies stably produced in milk and methods of producing same |
| 06/17/2004 | WO2004050846A2 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
| 06/17/2004 | WO2004050842A2 Atm kinase compositions and methods |
| 06/17/2004 | WO2004050838A2 Plant production of immunoglobulins with reduced fucosylation |
| 06/17/2004 | WO2004050837A2 Treatment of dna damage related disorders |
| 06/17/2004 | WO2004050836A2 Humanized antibodies against monocyte chemotactic proteins |
| 06/17/2004 | WO2004050834A2 GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER |
| 06/17/2004 | WO2004050708A2 Antibody for the thyrotropin receptor and uses thereof |
| 06/17/2004 | WO2004050707A2 Tumor-specific recognition molecules |
| 06/17/2004 | WO2004050706A2 Regulatory t-cells |
| 06/17/2004 | WO2004050704A1 Therapeutic and diagnostic agents |
| 06/17/2004 | WO2004050683A2 Antibodies directed to tumor necrosis factor and uses thereof |
| 06/17/2004 | WO2004050682A2 Phosphospecific pak antibodies and diagnostic kits |
| 06/17/2004 | WO2004050120A2 Treatment of prion-induced diseases by administration fo anti-prion antibodies |
| 06/17/2004 | WO2004050032A2 Antibodies against drugs of abuse |
| 06/17/2004 | WO2004050017A2 Rationally designed antibodies |
| 06/17/2004 | WO2004050016A2 Delivery of pharmaceutical agents via the human insulin receptor |
| 06/17/2004 | WO2004049917A2 Methods of therapy and diagnosis using targeting of cells that express ly-9 |
| 06/17/2004 | WO2004049794A2 Single chain antibodies produced in a transgenic mouse |
| 06/17/2004 | WO2004035607A8 Human monoclonal antibodies against cd20 |
| 06/17/2004 | WO2004033677A3 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 06/17/2004 | WO2004027421A3 Adp assay |
| 06/17/2004 | WO2004021000A9 Immunocapture-based measurements of mammalian pyruvate dehydrogenase complex |
| 06/17/2004 | WO2004020668A3 Method for treating synovial sarcoma |
| 06/17/2004 | WO2004018649A3 Monoclonal antibodies and complementarity-determining regions binding to ebola glycoprotein |
| 06/17/2004 | WO2004016753A3 Antibodies that immunospecifically bind to trail receptors |
| 06/17/2004 | WO2004003155A3 Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors |
| 06/17/2004 | WO2003102017A3 Anti-relp fusion antibodies, compositions, methods and uses |
| 06/17/2004 | WO2003095491A3 Antibody screening libraries |
| 06/17/2004 | WO2003093446A3 Antibodies for enhancing neurite outgrowth |
| 06/17/2004 | WO2003075831A3 NOVEL p53BP2 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME |
| 06/17/2004 | WO2003064992A3 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 06/17/2004 | WO2003059259A3 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 06/17/2004 | WO2003032810A3 Treatment and diagnosis of insulin resistant states |
| 06/17/2004 | WO2003018632A3 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 06/17/2004 | WO2003017992A3 Means for treatment of atherosclerosis |
| 06/17/2004 | WO2002086443A8 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 06/17/2004 | US20040117863 Preparing genetically engineered polypeptide for diagnosis and treatment of cell proliferative disorders; cancer therapy and tumor targeting |
| 06/17/2004 | US20040116676 Using nanofiltration to separate and isolate immunoglobulins from mixture containing viral particle inpurities; purifying human plasma |